Cart
sales@molnova.com
(E)-1-methoxy-2-O-(p-coumaroyl)-myo-inositol
CAS No. 1391715-18-6
(E)-1-methoxy-2-O-(p-coumaroyl)-myo-inositol( —— )
Catalog No. M32562 CAS No. 1391715-18-6
The herbs of Taxus cuspidata.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 50MG | Get Quote | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name(E)-1-methoxy-2-O-(p-coumaroyl)-myo-inositol
-
NoteResearch use only, not for human use.
-
Brief DescriptionThe herbs of Taxus cuspidata.
-
DescriptionThe herbs of Taxus cuspidata.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1391715-18-6
-
Formula Weight340.3
-
Molecular FormulaC16H20O8
-
Purity>98% (HPLC)
-
SolubilityDMSO, Pyridine, Methanol, Ethanol, etc.
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Grandifloroside
Grandifloroside shows good antioxidative and potent anti-inflammatory activities, it also exhibits potent inhibitory activity against TNF-α and 5α-reductase, suggests that it might be developed as a source of potent anti-oxidative and anti-inflammatory agents and therapeutic agent for benign prostatic hypertrophy (BPH).
-
Burosumab
Burosumab(KRN23) is a human monoclonal antibody targeting fibroblast growth factor 23 (FGF23) for the treatment of cutaneous-skeletal hypophosphatemic syndrome (CSHS) and tumor-induced osteochondrosis.
-
C188-9
C188-9 is a Stat3 inhibitor with an IC50 of 4-7 μM.
